Thursday, February 9, 2012

Subscribe to the IP Headline RSS feed | Subscribe to the IP Headline feed via Email

Appeals Court Confirms Patent Act Section 112′s Separate Written Description Requirement

A 9-2 en banc decision by the U.S. Court of Appeals for the Federal Circuit confirmed March 22 that Section 112 of the Patent Act contains a separate written description requirement beyond the requirement that a patent’s claims be enabled in the specification (Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., Fed. Cir., No. 2008-1248, 3/22/10).

cforms contact form by delicious:days

Comments

Please feel free to comment on this article...
You can obtain a picture to go with your comment at gravatar!